Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc

Inflammopharmacology

Volumn 26, Issue 5, 2018, Pages 1305-1316

  Haddadi, Rasool ^a,b   Poursina, Maryam ^b   Zeraati, Fatemeh ^a,b   Nadi, Forough ^b  

^a HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Catalepsy; Gastrodin; MDA; Myeloperoxidase; Parkinson disease; Rat; Rotarod

Indexed keywords

GASTRODIN; MYELOPEROXIDASE; NITRIC OXIDE; OXIDOPAMINE; BENZYL ALCOHOL DERIVATIVE; GLUCOSIDE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BAR TEST; CATALEPSY; CELL ACTIVATION; CONTROLLED STUDY; COORDINATION DISORDER; ENZYME ACTIVITY; EXPERIMENTAL LOCOMOTOR ACTIVITY TEST; LIPID PEROXIDATION; MALE; MICROGLIA; MICROINJECTION; MOTOR DYSFUNCTION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTAROD TEST; SUBSTANTIA NIGRA PARS COMPACTA; TREATMENT OUTCOME; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CHEMICALLY INDUCED; DRUG EFFECT; METABOLISM; OXIDATION REDUCTION REACTION; PARKINSONISM; WISTAR RAT;

ANIMALS; BENZYL ALCOHOLS; CATALEPSY; GLUCOSIDES; LIPID PEROXIDATION; MALE; MICROGLIA; MICROINJECTIONS; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDOPAMINE; PARKINSONIAN DISORDERS; PARS COMPACTA; PEROXIDASE; RATS; RATS, WISTAR;

EID: 85044774975     PISSN: 09254692     EISSN: 15685608     Source Type: Journal    
DOI: 10.1007/s10787-018-0470-4     Document Type: Article

References (43)

1. Benzie IF, Strain J (1999) [2] Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299:15–27
2. Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson’s disease. Front Neuroanat 9:91
3. Block M, Hong J (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127–1132
4. Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, Verna J-M (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172
5. Choi DK et al (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice. J Neurosci 25:6594–6600
6. Cohen G (1994) Free radicals, oxidative stress and neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. W. B Saunders, Philadelphia, pp 139–161
7. Cohen G (2000) Oxidative stress, mitochondrial respiration, and Parkinson’s disease. Ann N Y Acad Sci 899:112–120
8. Dai J-N et al (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS ONE 6:e21891
9. de Lau LM, Breteler M (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535
10. Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132–144. 10.1016/j.freeradbiomed.2013.01.018
11. Doo A-R et al (2014) Gastrodia elata Blume alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson’s disease mouse model. BMC Complement Altern Med 14:107
12. Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, Heinecke JW (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. J Neurochem 90:724–733
13. Haddadi R, Mohajjel Nayebi A, Brooshghalan SE (2013) Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats. Neurosci Lett 555:106–111
14. Haddadi R, Nayebi AM, Farajniya S, Brooshghalan SE, Sharifi H (2014) Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study DARU. J Pharm Sci 22:38
15. Haddadi R, Brooshghalan SE, Farajniya S, Nayebi AM, Sharifi H (2015) Short-term treatment with silymarin improved 6-OHDA-induced catalepsy and motor imbalance in hemi-parkisonian rats. Adv Pharm Bull 5:463–469. 10.15171/apb.2015.063
16. He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187–193
17. Hwang O (2013) Role of oxidative stress in Parkinson’s disease. Exp Neurobiol 22:11–17
18. Iancu R, Mohapel P, Brundin P, Paul G (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson’s disease in mice. Behav Brain Res 162:1–10
19. Ikawa M et al (2017) Dopaminergic neuronal oxidative stress is increased with disease progression in patients with Parkinson’s disease: a study with PET and SPECT: P4. 027
20. Jiang G, Hu Y, Liu L, Cai J, Peng C, Li Q (2014) Gastrodin protects against MPP+-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells. Neurochem Int 75:79–88
21. Kheradmand A, Mohajjel Nayebi A, Jorjani M, Haddadi R (2016a) Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats. Iran J Basic Med Sci 19:490–496
22. Kheradmand A, Nayebi AM, Jorjani M, Khalifeh S, Haddadi R (2016b) Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: possible involvement of oxidative stress and inflammatory cytokines. Neurosci Lett 627:7–12. 10.1016/j.neulet.2016.05.040
23. Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309–6316
24. Kumar H, Kim I-S, More SV, Kim B-W, Bahk Y-Y, Choi D-K (2013) Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson’s disease model. Evid-Based Complement Altern Med 2013:514095
25. Lefkowitz DL, Lefkowitz SS (2008) Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med 45:726–731
26. Li C, Chen X, Zhang N, Song Y, Mu Y (2012) Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson’s disease model rats. Neural Regen Res 7:325
27. Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1–7
28. Loeffler DA, Klaver AC, Coffey MP, Aasly JO, LeWitt PA (2017) Increased oxidative stress markers in cerebrospinal fluid from healthy subjects with parkinson’s disease-associated LRRK2 gene mutations. Front Aging Neurosci 9:89
29. McGeer P, Itagaki S, Boyes B, McGeer E (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38:1285
30. Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71
31. Mosley RL et al (2006) Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease. Clin Neurosci Res 6:261–281
32. Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916–3924
33. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Academic press, San Diego
34. Peng Z et al (2015) Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and inhibiting apoptosis pathway. Neurochem Res 40:661–673
35. Puthalakath H et al (2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129:1337–1349
36. Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah E (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol 155:31–41
37. Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827
38. Sharifi H, Nayebi A, Farajnia S, Haddadi R (2014) Effect of chronic administration of buspirone and fluoxetine on inflammatory cytokines in 6-hydroxydopamine-lesioned rats. Drug Res. 64:1–5
39. Sharifi H, Nayebi AM, Farajnia S, Haddadi R (2015) Effect of buspirone, fluoxetine and 8-OH-DPAT on striatal expression of bax, caspase-3 and Bcl-2 proteins in 6-hydroxydopamine-induced hemi-Parkinsonian rats. Adv Pharm Bull 5:491
40. Song C, Fang S, Lv G, Mei X (2013) Gastrodin promotes the secretion of brain-derived neurotrophic factor in the injured spinal cord. Neural Regen Res 8:1383
41. Sugama S et al (2003) Age-related microglial activation in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res 964:288–294
42. Tang W, Eisenbrand G (1992) Chinese drugs of plant origin. Chem Pharmacol Tradit Mod Med. 10.1007/978-3-642-73739-8
43. Zhang J-S, Zhou S-F, Wang Q, Guo J-N, Liang H-M, Deng J-B, He W-Y (2016) Gastrodin suppresses BACE1 expression under oxidative stress condition via inhibition of the PKR/eIF2α pathway in Alzheimer’s disease. Neuroscience 325:1–9